Bookmark and Share
hypothetical protein HP1089 [Helicobacter pyl.. [gi:15645703] - Target BioActivity Data
Also known as: hypothetical protein HP1089 [Helicobacter pylori 26695].
Filters: All Data » Active      
Filter selected
BioActivity Outcomes:
Active(1937)
 
 
BioAssay Types:
Screening(1902)
 
 
Confirmatory(19)
 
 
BioActivity Types:
IC50(19)
 
 
Substance Types:
Chemical(1937)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 7    Data Row: 1937   Total Pages: 97   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID144186606]
[CID1517823]
IC50 1.027Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex (ROUND 2) [AID651942, Type: confirmatory]
View
2
[SID110522925]
[CID2473636]
IC50 5.827Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex [AID504677, Type: confirmatory]
View
3
[SID144241483]
[CID2025521]
IC50 6.501Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex (ROUND 2) [AID651942, Type: confirmatory]
View
4
[SID110522927]
[CID771978]
IC50 7.542Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex [AID504677, Type: confirmatory]
View
5
[SID144241480]
[CID1398998]
IC50 7.653Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex (ROUND 2) [AID651942, Type: confirmatory]
View
6
[SID110522930]
[CID5341736]
IC50 9.421Late stage results for the probe development effort to identify inhibitors of AddAB recombination protein complex: Absorbance-based bacterial cell-based dose response assay for inhibitors of AddAB recombination protein complex [AID504677, Type: confirmatory]
View
7
[SID126920299]
[CID1517824]
IC50 11Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
8
[SID126496939]
[CID2930795]
IC50 11Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
9
[SID124343027]
[CID697851]
IC50 13Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
10
[SID126496932]
[CID697851]
IC50 17Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
11
[SID124343017]
[CID673474]
IC50 25Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
12
[SID124343048]
[CID1517823]
IC50 27Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
13
[SID110522932]
[CID1045135]
IC50 34Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
14
[SID124343023]
[CID793579]
IC50 36Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
15
[SID126496946]
[CID2983935]
IC50 55Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
16
[SID110522934]
[CID3157809]
IC50 55Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
17
[SID126920298]
[CID1960382]
IC50 79Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
18
[SID110522929]
[CID2743870]
IC50 93Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
19
[SID110522935]
[CID2295461]
IC50 96Late stage assay provider assay for AddAB inhibitors: Radioactivity-based biochemical dose response assay to identify inhibitors of the nuclease activity of purified AddAB [AID602421, Type: confirmatory]
View
20
[SID121282997]
[CID332389]
Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex [AID651984, Type: screening]
View